Trial Profile
Adjuvant Chemotherapy in Patients with Resected Non-Small-Cell-Lung Cancer Treated with Carboplatin and Oral Vinorelbine - SWITCH I Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2015
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary) ; Carboplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Acronyms SWITCH-I
- 19 Oct 2015 New trial record
- 06 Sep 2015 Results presented at the 16th World Conference on Lung Cancer.